- Home
- OGE vs IBRX Comparison
OGE vs IBRX Comparison
Compare OGE & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OGE | IBRX |
|---|---|---|
| Founded | 1902 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.4B | 8.2B |
| IPO Year | 2009 | 2015 |
Fundamental Metrics
Financial Performance| Metric | OGE | IBRX |
|---|---|---|
| Price | $46.92 | $8.08 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 7 |
| Target Price | ★ $48.78 | $12.57 |
| AVG Volume (30 Days) | 1.3M | ★ 7.2M |
| Earning Date | 04-29-2026 | 05-08-2026 |
| Dividend Yield | ★ 3.59% | N/A |
| EPS Growth | 5.94 | ★ 38.71 |
| EPS | ★ 0.24 | N/A |
| Revenue | ★ $3,260,100,000.00 | $113,288,000.00 |
| Revenue This Year | $3.74 | $88.59 |
| Revenue Next Year | $1.42 | $131.15 |
| P/E Ratio | $195.71 | ★ N/A |
| Revenue Growth | 9.21 | ★ 668.31 |
| 52 Week Low | $41.70 | $1.95 |
| 52 Week High | $50.59 | $12.43 |
Technical Indicators
Market Signals| Indicator | OGE | IBRX |
|---|---|---|
| Relative Strength Index (RSI) | 51.71 | 53.15 |
| Support Level | $46.86 | $7.77 |
| Resistance Level | $48.63 | $8.51 |
| Average True Range (ATR) | 0.73 | 0.35 |
| MACD | 0.09 | 0.01 |
| Stochastic Oscillator | 63.43 | 41.29 |
Price Performance
Historical ComparisonAbout OGE OGE Energy Corp
OGE Energy is a holding company for Oklahoma Gas & Electric, a regulated utility with electricity generation, transmission, and distribution service for 900,000 customers in Oklahoma and western Arkansas. In December 2021, OGE divested its 25.5% stake in Enable Midstream Partners, an oil and gas services company it created in 2013 through a unit exchange merger with Energy Transfer. OGE sold its 95.4 million limited partner units of Energy Transfer throughout 2022. OGE sold its retail gas business in 1928 and no longer has any gas operations.
About IBRX ImmunityBio Inc.
ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.